Topic: contract research organizations
California life sciences companies Twist Bioscience and LakePharma have penned a new pact to offer antibody discovery services to biopharma clients.
WuXi AppTec has hired Frederick Hausheer, M.D., as it looks to mine his clinical trial expertise for its boosted drug development offerings.
After a number of pacts and buyouts over the past few years, Charles River Labs is cutting staff at one of its California sites.
California data analytics company Saama Technologies has raised $40 million as it looks to bolster its artificial technology platform to “disrupt” clinical trials.
French biotech AlzProtect has teamed up with CRO Parexel for its midstage test of AZP2006 in patients with progressive supranuclear palsy.
Not content with hiring four former FDA staffers this month, Parexel is at it again, nabbing another top ex-FDA executive.
Charles River has added another string to its early-stage R&D bow by acquiring preclinical services firm Citoxlab for $510 million in cash.
The revolving door of FDA staffers into the life science industry continues as four former executives at the U.S. regulator join the CRO’s ranks.
U.K.-based CRO Clinigen has bought the rights to Novartis’ Proleukin (aldesleukin) outside the U.S. as it looks to boost sales.
Clinipace is bringing on new members of its C-suite to build out its role as a midsized CRO, after appointing a new CEO last fall.